On August 24, 2018, research paper entitled Nanomedicines reveal how PBOV1 promotes hepatocellular carcinoma for effective gene therapy was published on Nature Communications.

The First Affiliated Hospital, Sun Yat-sen University is the first author and correspondent author’s affiliation of the paper. The research is carried out by FAH Oncology-Nano Team which is led by Professor Kuang Ming, Director of Cancer Center and Visiting Professor Shuai Xintao.?